# Losing job/insurance and the options that follow

**URL:** <https://forum.fudiabetes.org/t/losing-job-insurance-and-the-options-that-follow/3330>\
**Category:** Insurance\
**Created:** [January 25, 2018, 1:32am UTC](https://forum.fudiabetes.org/t/losing-job-insurance-and-the-options-that-follow/3330 "2018-01-25T01:32:06Z")\
**Posts on this page:** 1\
**Showing post:** 146

<div class="post-metadata">

**Author:** ![kmichel](https://yyz2.discourse-cdn.com/flex030/user_avatar/forum.fudiabetes.org/kmichel/32/3085_2.png) [@kmichel](https://forum.fudiabetes.org/u/kmichel)\
**Post date:** [January 27, 2018, 9:11pm UTC](https://forum.fudiabetes.org/t/losing-job-insurance-and-the-options-that-follow/3330/146 "2018-01-27T21:11:45Z")

</div>

Gads. Time to put my foot in my mouth and support @Sam a bit … Seems like he is on his own here 😛

> [@cardamom](#):
>
> I’d switch to R and NPH before I’d cancel cable TV, personally.

I’d cancel the cable TV, but I would switch before canceling my internet… maybe even if I had to cancel internet, cell phone, etc.

> [@cardamom](#):
>
> proliferative diabetic retinopathy

Me too. And I developed it after 15 years on an insulin pump. So I can’t tie that to NPH/R, which I did relatively well on for the first 1/2 of my life. Exceptionally well, in fact. It was just that I had to follow a specific routine that did not work well for me in the long term. A pump was a better option, but the Humulin/Novolin was awful for me. Everyone’s mileage varies with every treatment.

I do know people who use beef/pork insulins (outside the US), as well as NPH.

In a [2016 market research study by Boston University](http://haiweb.org/wp-content/uploads/2016/04/ACCISS_Insulin-Market-Profile_FINAL.pdf), they said:

> _Glargine vs. NPH_  
> _All identified studies found no significant differences in HbA1c concentration after treatment_  
> \_with glargine compared to NPH. \_  
> _Detemir vs. NPH_  
> _None of the identified studies showed a significant difference in HbA1c concentration between_  
> _detemir and NPH treatment groups._

> [@Katers87](#):
>
> Can you give an example of a country that has made this work?

Meh - it is more like things are priced to the country and ability to pay. We in the US/Canda get to pick up the slack on the cost. I did see a post in another thread about Tresiba in Russia. It was funny to me, as they price it per milliliter, and not per box. I think the ad had 100 rubles per ml (about $15 USD). However, I have priced it there back in September '17 - it would cost me $300 per box. Humulog would cost me about $67 per vial.

But then there far more insulin producing companies in Asia, Eastern Europe, and Latin America versus high income countries (Again, see that Boston U report).

Just my $0.02 +/- worth.

---

_[View the full topic](https://forum.fudiabetes.org/t/losing-job-insurance-and-the-options-that-follow/3330)._